Expertise in
3
conditions

Shobhit Baijal

Birmingham, ENG, GB 
Expertise in
3
conditions
Birmingham, ENG, GB 

Overview

Shobhit Baijal practices practicing medicine in Birmingham, United Kingdom.

Baijal is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Ear Cancer, and Liver Transplant.

They are actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 3 clinical trials.

Locations

Birmingham, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Drug
Study Drug: Afatinib
Study Phase: Phase 2
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Biological
Study Drug: Enapotamab vedotin 
Study Phase: Phase 1/Phase 2
A Phase II Randomised, Open-label Study of Gemcitabine/Carboplatin First-line Chemotherapy in Combination With or Without the Antisense Oligonucleotide Apatorsen (OGX-427) in Advanced Squamous Cell Lung Cancers
A Phase II Randomised, Open-label Study of Gemcitabine/Carboplatin First-line Chemotherapy in Combination With or Without the Antisense Oligonucleotide Apatorsen (OGX-427) in Advanced Squamous Cell Lung Cancers
Enrollment Status: Unknown
Publish Date: August 22, 2017
Intervention Type: Drug
Study Drugs: Apatorsen, Gemcitabine, Carboplatin
Study Phase: Phase 2
View 2 Less Clinical Trials

18 Total Publications

Cost of managing brain metastases in patients with ALK+ advanced NSCLC with first-line tyrosine kinase inhibitors in the UK.
Cost of managing brain metastases in patients with ALK+ advanced NSCLC with first-line tyrosine kinase inhibitors in the UK.
Journal: Lung cancer management
Published: July 21, 2026

Frequently Asked Questions about Shobhit Baijal

Is Shobhit Baijal a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Shobhit Baijal is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shobhit Baijal participate in research or clinical trials?

Yes. Shobhit Baijal has published 18 articles and abstracts on conditions like Lung Cancer. You can view a list of Shobhit Baijal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Baijal's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile